𝗧𝗼𝗽 𝟯 𝗧𝗵𝗶𝗻𝗴𝘀 𝘁𝗼 𝗞𝗻𝗼𝘄 𝗔𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗦𝘂𝗿𝗲𝗦𝗲𝗾™ 𝗖𝗟𝗟 + 𝗖𝗡𝗩 𝗩𝟯 𝗣𝗮𝗻𝗲𝗹: 1. Enhanced gene coverage: The panel offers increased coverage for key genes like TP53, BTK, PLCG2, BCL2, and NRAS, aligning with the latest CLL research to provide a more comprehensive understanding of CLL progression. 2. High sensitivity and accuracy: The panel detects low-frequency SNVs and indels down to 1-2.5% VAF and CNVs down to 20% tumour estimation in the 5 most frequently aberrant regions, minimising the risk of missed variant calls. 3. Newly added internal reference DNA: This addition ensures accurate sample characterisation and increased lab efficiency by reducing inter-run variability. Check here for more details 👉 https://lnkd.in/e39WtpjN
Sysmex Europe Life Science’s Post
More Relevant Posts
-
How is Jona different from other gut #microbiome tests? We use a method of testing called shotgun metagenomics which offers a more comprehensive and detailed analysis than the 16S rRNA gene or PCR methods used by many other companies. Read our latest Jona Journal blog to learn why shotgun metagenomics is a superior and more reliable method of analysis of #guthealth. https://lnkd.in/gDpiywvX
-
UCLA Alumni and Double Bruin | Experienced in scRNA-seq statistical analysis and cell clustering
In Ovo micro-electroporation that can help understand auditory sensory development, including how the spatial and temporal patterns of sensor progenitor proliferation and hair cell differentiation are coordinated. Evsen L, Doetzlhofer A. Gene Transfer into the Chicken Auditory Organ by In Ovo Micro-electroporation. J Vis Exp. 2016 Apr 17;(110):53864. doi: 10.3791/53864. PMID: 27167684; PMCID: PMC4941936.
-
Connecting researchers to single cell multiomic solutions 🧬🔬| rowing & golf enthusiast
Here @ Sonny's BBQ on Inwood for the The University of Texas Southwestern Medical School Vendor Show! Come get some lunch & chat with our gene synthesis specialist Sofija Markovic and I about your omics needs and how we can support! #genesynthesis #ngs #geneexpression #multiomics #omicssolutions
-
-
Accelerate your gene function research with OriGene’s Lentiviral Products! 🚀 Efficiently knock down or overexpress genes with Lenti shRNA and Lenti-ORF options. Perfect for a variety of cell types. Click Here to Learn More: https://hubs.ly/Q02JDGmf0
-
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
Vice President (Technical) at Parexel; Regulatory and Technical CMC Consulting for Advanced Therapies and Biologicals
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
